I learned from my own experience that both in academia and pharmaceutics prompt identification and selection of an adequate database is very important. In academic setting analyzing the data from registries is particularly of great advantage in countries with limited financial resources for research which requires significant investment. In pharmaceuticals there is an increasing request from regulatory authorities for companies to conduct post-authorization safety studies. B.R.I.D.G.E. TO DATA contains detailed descriptions of databases from more than 40 countries, including descriptions of pregnancy registries. It is impressive that using B.R.I.D.G.E. TO DATA one can find information on databases even from small countries. The fact that B.R.I.D.G.E. has information on the Serbian Pharmacovigilance Database speaks for itself.

This "database" of databases is very useful in my day-to-day activities as it allows me to find quickly which databases will fit the best regarding the research questions I have. It is very complete and contains information on countries for which it is sometimes difficult to find information elsewhere.

B.R.I.D.G.E. TO DATA has been very helpful for initial screening data sources for a potential epi study. It provides broad, thorough, and detailed information on each database listed in the system.  It has been a wonderful tool to have, especially for feasibility evaluation.